Pilot study of the combination of capecitabine plus oxaliplatin as adjuvant therapy for patients with stage III and high risk stage II colon cancer

被引：0
|
作者：
Olier, C. [1 ]
Reyna, C. [1 ]
Aramendia, J. M. [1 ]
Rodriguez, J. [1 ]
Viudez, A. [1 ]
Chopitea, A. [1 ]
Garcia-Foncillas, J. [1 ]
机构：
[1] Univ Navarra Clin, Pamplona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15093
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
    Dimitrios Pectasides
    Vasilios Karavasilis
    George Papaxoinis
    Georgia Gourgioti
    Thomas Makatsoris
    Georgia Raptou
    Eleni Vrettou
    Joseph Sgouros
    Epaminontas Samantas
    George Basdanis
    Pavlos Papakostas
    Dimitrios Bafaloukos
    Vassiliki Kotoula
    Haralambos P. Kalofonos
    Chrisoula D. Scopa
    George Pentheroudakis
    George Fountzilas
    BMC Cancer, 15
  • [22] Cumulative dose of oxaliplatin in adjuvant therapy for stage III colon cancer patients: Impact on survival
    Zok, Jolanta
    Radecka, Barbara
    Adamowicz, Krzysztof
    Jan, Korniluk
    Duchnowska, Renata
    Wysokinska, Ewa Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study
    Sha, Aaron
    Abadi, Shirin
    Gill, Sharlene
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (07) : 501 - 506
  • [24] Adjuvant therapy of stage III colon cancer
    Sun, Weijing
    Haller, Daniel G.
    CHINESE CLINICAL ONCOLOGY, 2013, 2 (02)
  • [25] Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
    Hata, Taishi
    Uemura, Mamoru
    Danno, Katsuki
    Yoshioka, Shinichi
    Matsuda, Chu
    Kagawa, Yoshinori
    Shingai, Tatsushi
    Suzuki, Yozo
    Tei, Mitsuyoshi
    Tanida, Tsukasa
    Komori, Takamichi
    Okamura, Shu
    Ota, Hirofumi
    Takemoto, Hiroyoshi
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Yamamoto, Hirofumi
    Murata, Kohei
    Doki, Yuichiro
    Eguchi, Hidetoshi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Capecitabine based adjuvant therapy for stage III colon cancer - single institution experience
    Mitreski, N.
    Angelovska, N.
    Grozdanovska, B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S15 - S15
  • [27] Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for Stage II and III rectal cancer
    Jin, Jing
    Li, Ye-Xiong
    Wang, Jin-Wan
    Wang, Wei-Hu
    Liu, Yue-Ping
    Wang, Kai
    Fang, Hui
    Zhou, Zhi-Xiang
    Zhou, Ai-Ping
    Yu, Zi-Hao
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 671 - 677
  • [28] Administration of adjuvant oxaliplatin to patients with stage III colon cancer is affected by age and hospital
    van Erning, Felice N.
    Bernards, Nienke
    Creemers, Geert-Jan
    Vreugdenhil, Art
    Lensen, Chantal J. P. A.
    Lemmens, Valery E. P. P.
    ACTA ONCOLOGICA, 2014, 53 (07) : 975 - +
  • [29] Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial
    Schmoll, Hans-Joachim
    Tabernero, Josep
    Maroun, Jean
    de Braud, Filippo
    Price, Timothy
    Van Cutsem, Eric
    Hill, Mark
    Hoersch, Silke
    Rittweger, Karen
    Haller, Daniel G.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3733 - +
  • [30] Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: a pharmacogenetic ancillary study to TOSCA trial
    Ruzzo, A.
    Galli, F.
    Galli, F.
    Rulli, E.
    Lonardi, S.
    Zagonel, V.
    Ronzoni, M.
    Ionta, M. T.
    Pella, N.
    Mucciarini, C.
    Labianca, R.
    Veltri, E.
    Sozzi, P.
    Barni, S.
    Nicolini, M.
    Biondi, E.
    Bramati, A.
    Turci, D.
    Buscaglia, M.
    Magnani, M.
    Graziano, F.
    ANNALS OF ONCOLOGY, 2017, 28 : 4 - 5
12345